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Site-2 protease (S2P) is a membrane-embedded protease that site-specifically cleaves intramembrane
transcription factors, a necessary step for their maturation. S2P is well known to regulate cholesterol
biosynthesis and endoplasmic reticulum stress in mammalian cells. In this study, we hypothesized that S2P
could be responsible for the regulation of cellular oxidative injury under oxidative stress. Wild type Chinese
hamster ovary (WTCHO) cells and theirmutantM19 cells with defective S2P genewere exposed to different
oxidative stress conditions. Results showed that oxidative stress significantly up-regulated S2P expression in
WTCHO cells. Notably, M19 cells had remarkably higher level of superoxide and elevated rates of cell death
than WT CHO cells. The vulnerability to oxidative stress was reversed by the transfection of S2P gene but
not rescued by exogenous supplement of cholesterol, oleate, and mevalonate, indicating that lack of S2P
gene leads cells to be more vulnerable to oxidative stress. Furthermore, compared withWT CHO cells, M19
cells had higher nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and lower
paraoxonase-2 expression. Taken together, these results suggest that S2P can be a protease responding to
oxidative stress and has the function of regulating cellular oxidative injury.
S
equential cleavage, a process designated as regulated intramembrane proteolysis, is required formaturation
of intramembrane transcription factors1–3. It includes in tandem cleavages at specific sites of substrates by
two membrane embedded proteases accordingly: site-1 protease (S1P) and site-2 protease (S2P)1–3. As a
hydrophobic integral membrane protease, S2P is essential for cholesterol biosynthesis in mammalian cells owing
to its activation of the sterol regulatory element binding proteins (SREBPs), a group of critical transcription
factors regulating cholesterol uptake and synthesis4–6. SREBPs bind to sterol regulatory element of DNA and
trigger transcription of dozens genes controlling lipid metabolism. Normally, SREBPs are inactive precursors at
endoplasmic reticulum (ER). In response to low level of cellular cholesterol, SREBPs can be transported from ER
membrane to Golgi and sequentially cleaved by S1P and S2P. The resulting released N-terminal domain is then
translocated to nucleus, starting transcription of genes encoding key enzymes involved in the uptake and
synthesis of cholesterol and fatty acid, including 3-hydroxy-3-methylglutaryl coenzymeA (HMG-CoA) synthase,
HMG-CoA reductase and so on6–9. The resultant increase of cholesterol feedback inhibits SREBPs transport and
cleavage10,11. Through the S2P cascade, the cholesterol feedback pathway is stringently regulated. Meantime, S2P
plays crucial roles in regulating ER stress through sequential cleavage in response to unfolded proteins and ER
stress signaling by using the transcription factors as substrates including activating transcription factor 6
(ATF6)12,13, cAMP response element binding protein homolog14 and old astrocyte specifically-induced sub-
stance15–17. However, whether S2P has other biological functions is unknown yet.
After S2P gene was cloned in 1997, scientists started to explore the roles of this intramembrane protease in
different pathological states. Dysfunction of intramembrane proteases is linked to diverse signaling pathways2,18
and several diseases such as familial Alzheimer’s disease19,20, Parkinson’s disease21 and diabetes22. Occurrence and
progression of these diseases are associated with free radicals and oxidative stress23. Recent evidence indicates that
intramembrane proteases have the potentials tomodulate oxidative stress, whichmay impact the process of those
diseases. For example, paraoxonase-2 (PON-2) is a ubiquitous expressed cellular anti-oxidative enzyme that
reduces reactive oxygen species (ROS) mediated cellular injury24,25 and PON-2 is a target gene of SREBP-226. Sre-
1, the yeast ortholog of SREBPs, functions as an oxygen sensor and stimulates transcription of genes for hypoxia
adaptation in fission yeast27. Therefore, how S2P regulates oxygen sensor SREBPs cleavage and oxidative stress is
an interesting question. In this study, we designed a series of experiments to test the hypothesis that S2P could
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regulate oxidative stress through promoting SREBP-2 cleavage and
PON-2 expression, and inhibiting nicotinamide adenine dinucleo-
tide phosphate (NADPH) oxidase.
Results
Oxidative stress induced S2P mRNA expression inWT CHO cells
and brain microvascular endothelial cells.We first challenged WT
CHO cells with different oxidative stress conditions, including
xanthine/xanthine oxidase (X/XO), menadione sodium bisulfate
(MSB), H2O2 and hypoxia. As a classic free radical generating
system, xanthine oxidase catalyzes the substrate xanthine to
produce superoxide (O2?2). Cells were treated with 100 mM
xanthine plus different units (0.2, 0.5, 1 mU) of xanthine oxidase
for 2 h;Menadione (2-methyl-1,4-naphthoquinone or vitamin K3), a
polycyclic aromatic ketone, can generate O2?2 through redox cycling
and glutathione depletion. As water soluble form of menadione,
(MSB) commonly works as endogenous oxidative stress reagent.
Cells were incubated with 20, 50, 100 mM of MSB; Hydroxyl
peroxide (H2O2) and hypoxia are commonly used as extraneous
and endogenous oxidative stress models respectively. As showed in
Figure 1A–E, treatments of H2O2, MSB and X/XO up-regulated the
expression of S2P mRNA in WT CHO cells. Meanwhile, hypoxic
treatment also induced the expression of S2P mRNA in WT CHO
cells. To elucidate whether other cells have similar responses of S2P
gene to oxidative stress, mouse brain microvascular endothelial
bEnd.3 cells was applied in the study. Similarly, both X/XO and
H2O2 dose-dependently induced the increased expression of S2P
mRNA in bEnd.3 cells (Figure 1F–G). Those results suggest that
S2P could be a protease being sensitive to oxidative stress.
S2P deficiency increased cellular vulnerability to oxidative stress.
We next investigated the function of S2P in regulating cellular
oxidative injury. M19 cells, which are specifically defective in S2P
gene28–30, were used in the study. Hydroethidine (HEt)-staining,
fluorescence microscopy and flow cytometery were used to detect
superoxide production. After exposed to 100 mM xanthine plus
0.2 mU xanthine oxidase (Figure 2A), 15 h hypoxia (Figure 2C) or
20 mM to 100 mM MSB (Figure 3A, 3C), M19 cells had remarkably
higher HEt-staining fluorescence than WT CHO cells. In agreement
with the results, transfection of S2P gene into M19 cells abolished
HEt-staining fluorescence under different oxidative stress conditions
including X/XO (Figure 2B), hypoxia (Figure 2D) and MSB
(Figure 3B, 3C). Those results indicate that deficiency of S2P could
induce relatively high level of superoxide production in cells.
We then detected the release of LDH into cultured medium as an
index of cell death. After exposed to X/XO, MSB and hypoxia, M19
cells hadmuch higher LDH level in cultured medium thanWTCHO
cells (Figure 4A–C). We then compared S2P-transfected M19 cells
(M19-S2P) and Mock vector transfected M19 cells (M19-Mock) in
the release of LDH into medium under oxidative stress. Notably, the
M19-S2P cells displayed remarkably lower level of LDH release than
the M19-Mock cells under oxidative stress (Figure 4A–C). These
Figure 1 | RT-PCR assay for determining relative mRNA expression level of S2P gene in CHO and M19 cells treated with several oxidative stress
conditions. The conditions included (A) 0.001 and 0.01%H2O2 with or without 100 U/ml catalase for 1 h, (B) 50 and 100 mMMSB for 2 h, (C) hypoxia
(1%O2 and 5%CO2 balanced with N2) for 6, 12, 24 h, and (D) 100 mMxanthine plus 0.2 or 1 mU/ml xanthine oxidase (X/XO) for 2 h. b-actin was used
as internal loading control. (E) S2PmRNA level in oxidative stress conditions were quantified with ImageJ software and shown in bar graph. (F) RT-PCR
assay for determining relative mRNA expression level of S2P gene in bEnd.3 cells, a mouse brain microvascular cell line. b-actin was used as internal
loading control. (G) S2P expression in bEnd.3 cells were quantified and shown in bar graph. Full length images are presented in supplementary
information (Supplementary Figure S1 and S2). The relative fold changes were expressed as mean 6 SD, n 5 3. * p , 0.05, ** p , 0.01. The results
showed that oxidative stress induced S2P mRNA expression in CHO and bEnd.3 cells.
www.nature.com/scientificreports
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results indicate that lacking S2P could increase cellular vulnerability
to oxidative stress.
M19 cells, selected for resistance to amphotericin B, have low level
of intracellular cholesterol and unsaturated fatty acid due to the
deletion of the gene encoding the S2P protease that cuts the
SREBP at site 230. One may argue that low intracellular level of
cholesterol or unsaturated fatty acid, instead of S2P gene itself, might
contribute to the enhanced superoxide production and vulnerability
to oxidative stress. To address this question, the cells were incubated
with 50 mM methyl-b-cyclodextrin cholesterol (MbCD-chol), or
sodium oleate, or mevalonate (to provide nonsterol isoprenoids)
for 2 h. The increased intracellular free cholesterol and cholesterol
esters were confirmed with a microenzymatic fluorescence assay as
our previous report31. Incorporation of cholesterol with these lipids
had no effect on superoxide production and cell death in M19 cells
after challenged with MSB or X/XO (Figure 5A–D). Those results
suggest that S2P deficiency itself, instead of lipid deficiency, contri-
butes to the enhanced cellular oxidative injury in M19 cells under
oxidative stress.
S2P deficiency had no effect on the expression of ATF6 and SOD
during oxidative stress. We then addressed whether ER stress
associated proteins and antioxidant enzymes contribute to the
enhanced vulnerability to oxidative stress in S2P null M19 cells.
ATF-6 is a substrate of SREBP-2 and transcription factor in
response to unfolded protein under ER stress and may involved in
the regulation of oxidative stress. As an ER-resident protein, ATF-6
binds to the ER chaperone binding immunoglobulin protein (BiP)
under normal physiological conditions32. During ER stress, BiP binds
to unfolded proteins releasing ATF6 which translocates to the Golgi
apparatus and is cleaved by S1P and S2P to release the domain with
transcriptional activity12,13. The increased ATF6 expression was found
in various oxidative stress conditions including hypoxia and ischemia/
reperfusion33–35. In the present study, compared with WT cells, M19
cells had no significant difference in the expression of ATF-6 (90 KD)
under normoxic and hypoxic conditions (Figure 6A). Meanwhile,
hypoxia could not induce a detectable ATF-6 cleavage (,50 KD) in
WT and M19 cells (Figure 6A). Furthermore, after exposed to X/XO
and hypoxia, M19 cells had no significant difference in the
expressions of SOD-1 and SOD-2 in comparison with WT CHO
cells (Figure 6B–C). These data indicate that S2P deficiency has no
influence on the expression of ER stress associated proteins and
antioxidant enzymes during oxidative stress.
SREBP-2/PON-2 pathway was involved in the vulnerability of CHO
cells with deficiency of S2P. PON-2, a target gene of SREBP-2, is a
ubiquitously expressed anti-oxidative enzyme24,25. PON-2 is response
to ROS, mediates the reduced susceptibility to oxidative stress36 and
counteracts lipid peroxidation at the plasma membrane37. To study
whether PON-2 is involved in anti-oxidative regulation of S2P, we
detected the expression of PON-2 in WT CHO and M19 cells under
hypoxic condition. As showed in Figure 7A, after exposed to 15 h
hypoxia, WT CHO cells instead of M19 cells had remarkably up-
regulated the expression of PON-2, suggesting that S2P might be
essential for oxidative stress mediated PON-2 activation. To further
confirm this phenomenon, we transfectedM19 cells with S2P, active
form of SREBP-2 (cleaved SREBP-2, cSREBP-2) or Mock vector, then
compared the expression of PON-2 and the rate of cell death.
Consistently, S2P and cSREBP-2 transfection rescued the expression
of PON-2 in response to hypoxic treatment. Furthermore, S2P and
Figure 2 | Hydroethidine (HEt) staining and observation with fluorescent microscopy for detecting superoxide in CHO and M19 cells treated with
xanthine plus xanthine oxide (X/XO) and hypoxia. (A) The intracellular superoxide detection in CHO andM19 cells treated with xanthine (X, 100 mM)
plus xanthine oxide (XO, 0.2 mU) for 2 h. (B) Superoxide detection in M19 cells transfected with empty vector (Mock) or S2P expressive vector (S2P)
followed by treatment with X/XO (X: 100 mM; XO: 0.2 mU) for 2 h. (C) CHO and M19 cells were exposed at normoxic condition (atmospheric O2
concentration in the incubator containing 5% CO2) or hypoxic condition (1% O2) for 15 h followed by HEt staining and fluorescent microscopic
observation. (D)M19 cells transfected withMock and S2P vector followed 15 h hypoxic treatment. The results showed that S2P could reduce superoxide
production induced by X/XO and hypoxia.
www.nature.com/scientificreports
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cSREBP-2 overexpression inM19 cells significantly reduced the rate of
cell death under hypoxia. Those results suggest that S2P might play
essential roles in regulating antioxidant activities in response to
oxidative stress through regulating SREBP-2/PON-2 pathway.
M19 cells had higher NADPH oxidase activity and more elevated
expression of subunit gp91-phox than in WT CHO cells under
hypoxic condition. To explore whether anti-oxidative activity of
S2P is related to regulate NADPH oxidase, we detected NADPH
oxidase activity by using lucigenin-enhanced chemiluminescence
assay and investigated the expressions of NADPH oxidase subunits
including gp91-phox, p47-phox, p67-phox and p22-phox with
Western blot analysis. The results were shown in Figure 8A–D.
Compared with normoxia, hypoxic treatment resulted in more
Figure 3 | HEt staining followed by fluorescence microscopic observation and flow cytometery for determining superoxide level after treatment with
MSB in CHO,M19, M19 cells transfected withMock and S2P vector. (A) Fluorescent picture of HEt staining in CHO andM19 cells treated with 20 mM
MSB for 2 h. (B) Fluorescent picture of HEt staining under treatment of 20 mM MSB for 2 h in M19 cells transfected with Mock or S2P vector. (C)
Percentages of HEt positive cells were determined by flow cytometery in CHO andM19 cells with or without transfection of S2P gene. The percentages of
positive staining cells were expressed as mean6 SD, n5 3. Statistical analysis was done by ANOVA. * p, 0.05, ** p, 0.01. The results showed that S2P
reduced superoxide production induced by MSB.
Figure 4 | Lactate dehydrogenase (LDH) release assay for determining the rate of cell death in CHO and M19 cells treated with X/XO, hypoxia and
MSB. (A) is the rate of cell death under the treatment of 100 mMXplus 0.2 and 1 mUXO for 2 h in CHO,M19,M19 cells transfected withMock and S2P
vector. (B) is the rate of cell death under 15 h hypoxia in CHO, M19, M19 cells transfected with Mock and S2P vector. (C) is the rate of cell death
under the treatment of 20 and 100 mMMSB for 2 h in CHO, M19, M19 cells transfected with Mock and S2P vector. The percentages of cell death were
expressed as mean 6 S.D. n 5 3. Statistical analysis was determined by ANOVA. * p, 0.05. ** p, 0.01. The results showed that S2P reduced the cell
death induced by X/XO, hypoxia and MSB.
www.nature.com/scientificreports
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than 2 folds increase in the expression of NADPH oxidase in M19
cells rather than WT CHO cells. S2P transfection remarkably
abolished the induction of NADPH oxidase in the M19 cells.
Moreover, after exposed to 15 h hypoxia, M19 cells had the up-
regulated expression of gp91-phox, the catalytic subunit of NADPH
oxidase, whereas S2P transfection into M19 cells restored gp91-phox
to normal level. There was no significant change in expressions of
p47-phox, p67-phox and p22-phox (data not shown). Therefore, S2P
might have inhibitory effects on NADPH oxidase activity through
down-regulating gp91-Phox subunit under hypoxic condition.
Discussion
S2P is an intramembrane protease participating in regulating lipid
metabolism and ER stress but other physiological functions are lar-
gely unknown. In present study, we are the first to report a novel
function of S2P serving as antioxidant regulating protein in response
to oxidative stress. S2P protects mammalian cells from oxidative
injury through up-regulating SREBP-2/PON-2 pathway and inhib-
iting NADPH oxidase.
S2P is an important signaling mechanism conserved from bacteria
to human beings in regulated intramembrane proteolysis3,38. The
critical step of this process is the site-specific cleavage of transmem-
brane transcription factors by S2P within the lipid bilayer. Although
the S2P-mediated proteolysis was intensively investigated in last
decades, little is known about the roles of S2P in regulating oxidative
stress. Previous study reported an interesting phenomenon that Sre-
1, the substrate of yeast S2P, was cleaved and activated, subsequently
mediating transcription of genes encoding oxygen-depending
enzymes in response to lower oxygen in fission yeast27. In present
study, we stepped forward to report that S2Pmight be an antioxidant
regulating proteins in mammalian cells in response to oxidative
stress. This conclusion was derived from the systematic experiments
with different mammalian cells and their mutant cells with the defi-
ciency and transfection of S2P under both endogenous and extrane-
ous oxidative stress models. Hypoxia was used as endogenous
oxidative stress model and treatments of X/XO, MSB and H2O2
applied for extraneous oxidative stress. The increased S2P mRNA
was consistently found in both WT CHO cells and mouse brain
microvascular endothelial bEnd.3 cells under different oxidative
stress conditions, indicating that S2P is sensitive to oxidative stress.
To elucidate the functions of S2P in regulating oxidative stress, we
appliedWTCHOcells andM19 cells, which were derived fromCHO
cells with specifically defective in S2P gene. Under oxidative stress
conditions, M19 cells revealed remarkably higher superoxide level
and higher rate of cell death than WT CHO cells. Furthermore,
transfection of S2P vector into theM19 cells restored the antioxidant
ability. Those results appear to support that conclusion that S2P
could regulate oxidative stress. However, mounting evidence indi-
cates the relationship between cellular cholesterol level and oxidative
stress39–41. S2P plays essential roles in cholesterol biosynthesis by
cutting the SREBP at site 2. As M19 cells have low level of intracel-
lular cholesterol and unsaturated lipids due to the deletion of S2P
protease. We should eliminate the potential affects that low lipid
level, rather than S2P gene itself, might contribute to the enhanced
Figure 5 | HEt staining and LDH release assay for detecting superoxide level and the rates of cell death, respectively, inM19 cells with or without water
soluble cholesterol MbCD-chol, sodium oleate and mevalonate. (A) is the superoxide detection in M19 cells treated with MSB (50 mM) or X/XO (X,
100 mM; XO, 0.5 mU) with or without 50 mMMbCD-chol for 2 h. (B) is the rate of cell death with the same treatments. (C) is superoxide detection in
M19 cells treated with X/XO (X, 100 mM; XO, 0.5 mU) with or without 1 mM sodium oleate and 100 mMmevalonate for 2 h. (D) is the rate of cell death
with the same treatments. The percentages of cell death were expressed as mean 6 S.D. n 5 3. Statistical analysis was done by ANOVA. n.s.: no
significance. The results showed that lipids incorporation did not affect cellular superoxide level and cell death induced by MSB and X/XO.
www.nature.com/scientificreports
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superoxide production and vulnerability to oxidative stress. Thus we
conducted lipid incorporation experiments. The results revealed that
incorporation of cholesterol and unsaturated lipids had no effect on
superoxide production and cell death in M19 cells. Thus, we con-
clude that S2P is a player in regulating oxidative stress induced
cellular injury.
We then addressed potential mechanisms of S2P in regulating
oxidative stress. S2P is a player for regulating ER stress through
the sequential cleavage in response to unfolded protein and ER stress
signaling by using the transcription factors as substrates including
ATF612,13. ATF-6 is a substrate of SREBP-2 and transcription factor
in response to unfolded protein under ER stress and may involve in
the oxidative stress regulation. We logically investigated the express-
ion of ATF6. The results revealed that M19 cells had similar express-
ion level of ATP-6 to WT CHO cells under both normoxia and
hypoxia, indicating the increased vulnerability to oxidative stress
might not be related to ER stress. As a target gene of SREBP-2,
PON-2 was reported to regulate the susceptibility to oxidative stress
in different experimental systems24–26. We subsequently investigated
the roles of PON-2 in our experiments. Under hypoxic condition,
gain and loss of S2P and cSREBP-2 in the CHO cells remarkably
altered PON-2 expression, indicating that S2P enzymatic activity
might regulate PON-2 expression and oxidative injury. In addition,
we studied the expression and activities of NADPH oxidase, an
important source of ROS, in the experiments. Compared with WT
CHO cells, M19 cells had enhanced expression level of gp91-phox,
the catalytic subunit of NADPH oxidase42, and increased NADPH
oxidase activity after exposed to hypoxic condition, indicating that
deficiency of S2P might inhibit SREBP-2/PON-2 signaling and pro-
mote NADPH oxidase activity. Those results, when taken together,
provide strong evidence to support the function of S2P as an anti-
oxidant protein under oxidative stress.
In conclusion, S2P could function as an antioxidant protein for
regulating oxidative injury. The anti-oxidative role of S2P could be
related to the regulation of PON-2 expression and NADPH oxidase
activity. This study provides a new cue for understanding cellular
defense mechanisms against oxidative injury. Its physiological func-
Figure 6 | Western blot assay to detect protein expressions of ATF6,
SOD-1 and SOD-2 inCHOandM19 cells treatedwithX/XOand hypoxia.
(A) Protein expression level of ATF-6 in CHO-WT and M19 cells exposed
on normoxia and 15 h hypoxia. (B–C) Protein level of SOD-1 and SOD-2
in CHO and M19 cells treated with 100 mM plus 0.2 and 0.5 mM XO or
15 h hypoxia. Full length blots are presented in supplementary
information (Supplementary Figure S3). The results showed that hypoxia
did not induce significant changes of ATF-6 and SOD between CHO and
M19 cells.
Figure 7 | Western blot assay for determining SREBP-2 and PON-2 protein expressions under 15 h normoxia or hypoxia in CHO, M19, M19 cells
transfected with S2P, cSREBP-2 orMock vectors. (A–C) is theWestern blot picture of SREBP-2 and PON-2. (D–E) is the rate of cell death with the same
treatments. The percentages of cell death were expressed as mean6 S.D. n5 3. Statistical analysis was done by ANOVA. * p, 0.05, n.s.: no significance.
Full length blots are presented in supplementary information (Supplementary Figure S4). The results showed that S2P was required for the PON-2
elevation in response to hypoxia.
www.nature.com/scientificreports
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tions and implications in different physiological and pathological
conditions remain to be further studied.
Methods
Cell culture. Wild type Chinese hamster ovary (WT CHO) cells were obtained
originally from ATCC (Manassas, VA, USA). M19 cells, the mutant CHO cell line
which has defective in S2P gene, were developed and provided by Professor Ta Yuan
Chang’s laboratory at DartmouthMedical School, USA.WTCHO cells andM19 cells
were grown as a monolayer in Ham’s F-12 (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% (v/v) fetal bovine serum (FBS, Invitrogen) and 10 mg/ml
antibiotics (penicillin and streptomycin, Invitrogen). After cell density reached to
about 70% confluence, the cells were pre-incubated in serum-free medium over-
night. Meanwhile, mouse brain microvascular endothelial bEnd.3 cells were obtained
fromATCC and cultured in DMEM supplemented with FBS and antibiotics. The rest
protocol for bEnd.3 cells is the same as that of CHO cells.
Oxidative stress and lipids incorporation. Cells were cultured in the medium
without serum and then exposed to four different oxidative stress conditions: (1)
Menadione treatment: Menadione (2-methyl-1,4-naphthoquinone or vitamin K3), a
polycyclic aromatic ketone, is commonly used as oxidative stress reagent that can
generate superoxide anion through redox cycling43–45. Cells were incubated with 20,
50, 100 mM of menadione sodium bisulfate (MSB, Sigma, St. Louis, MO, USA), a
water soluble form of menadione, for 2 h at 37uC; (2) Xanthine plus xanthine oxidase
(X/XO) treatment: To induce superoxide anions, cells were treated with 100 mM
xanthine (Sigma) plus different units (0.2, 0.5, 1 mU) of xanthine oxidase (Sigma) for
2 h; (3) H2O2 treatment: Cells were incubated with H2O2 solution (Merck,
Darmstadt, Germany) at the concentrations of 0.001% and 0.01% for 1 h with or
without 100 U/ml catalase (Sigma). (4) Hypoxia treatment: Cells were incubated in
hypoxia chamber (Billups-Rothenberg, DelMar, CA,USA) perfused with themixture
gas containing 95% N2 and 5% CO2. O2 concentration was monitored with PA-10A
paramagnetic O2 analyzer (Sable Systems International, Las Vegas, NV, USA). After
O2 concentration reached to 1%, cells were continuously exposed to the hypoxic
environment for 6, 12 and 24 h.
In a parallel study, lipids incorporation experiments were conducted in M19 cells.
Water soluble cholesterol (50 mM, cholesterol-methyl-b-cyclodextrin, MbCD-Chol,
Sigma), sodium oleate (1 mM, Aladdin Reagents, Shanghai, China) and mevalonate
(100 mM, Aladdin Reagents) were added into the culture medium prior to the
treatments of oxidative stress. RNA or proteins were extracted. Reverse transcription-
PCR and Western blot analysis were performed to detect the expressions of specific
mRNA and protein respectively.
S2P and cSREBP-2 gene transfection with Lipofectamine 2000. Before undergoing
the transfection procedure, M19 cells were seeded on 6-well plates with antibiotics
and serum-freemedium. The full-length S2P gene was inserted into expression vector
pCMV-HSV or with specific restriction endonucleases. The vector containing S2P,
cSREBP-2 or empty vector (Mock) and Lipofectamine 2000 were diluted in Opti-
MEM (Invitrogen). Then DNA and Lipofectamine 2000 were mixed and incubated
for 20 min at room temperature to form DNA-Lipofectamine 2000 complex and
incubated in culture medium with the cells for 5 h followed by replacement of
medium with serum and antibiotics. After 24 h transfection, cells were prepared for
treatment and observation.
RNA extraction and RT-PCR. Total RNA was extracted by TRIzolH reagent
(Invitrogen) according to product manual. RNA was quantified and underwent the
SuperScript first-stand synthesis system for RT-PCR (Invitrogen). S2P transcript was
amplified with forward (59-GTT GGGGTG CTC ATC ACT GAA-39) and backward
(59-CAT TAC CGT GCT GTA ACC ATC CAG-39) primers, yielding a PCR product
of 790 bases. Housekeeping gene b-actin (internal control) was amplified with
forward, 59-CTA CAA TGA GCT GCG TGT GGC-39, and backward, 59-CAG GTC
CAG ACG CAGGAT GGC-39, primers, producing a PCR product of 270 bases. The
annealing temperature was 51uC for S2P and 55uC for b-actin amplification. 40 and
30 cycles were used for S2P and b-actin respectively.
Figure 8 | Lucigenin enhanced chemiluminescence and Western blot assay for detecting NADPH oxidase activity and expression level of gp91-phox
respectively. (A) NADPH oxidase activity in CHO and M19 under normoxia and 15 h hypoxia. The activity was normalized with the one in CHO cells.
(B) NADPH oxidase activity in M19 cells transfected with empty or S2P vector under normoxia and 15 h hypoxia. The activity of each group was
normalized with the one in M19-Mock. (C–D) Protein expression levels of NADPH oxidase subunit gp91-phox in each group under normoxia and 15 h
hypoxia. b-actin was used as loading control. The relative fold changes of NADPH oxidase activity were expressed as mean 6 S.D. n 5 3. Statistical
analysis was done by ANOVA. * p, 0.05. Full length blots are presented in supplementary information (Supplementary Figure S5). The results showed
NADPH oxidase increased in M19 cells under hypoxia.
www.nature.com/scientificreports
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Western blot analysis.Cell lysates were prepared with RIPA lysis buffer (Sigma) plus
protease inhibitors cocktail (Merck) and denatured prior to resolved on 10% to 12%
SDS-PAGE. Proteins were then transferred to polyvinylidene difluoride membranes
(Millipore, Billerica, MA, USA). After blocking, membranes were incubated with
primary antibodies overnight at 4uC followed by washing and secondary antibody
incubation. Antibodies included SOD-1 (Cu-Zn SOD, 151000, Santa Cruz, CA,
USA), SOD-2 (Mn-SOD, 151000, Santa Cruz), b-actin (155000, Santa Cruz), PON-2
(15500, Abcam, Cambridge, UK), P22-phox (15500, Santa Cruz), P47-phox (15500,
Millipore), P67-phox (151000, Millipore), gp91-phox (151000, Millipore), SREBP-2
(151000, Abcam) and ATF-6 (151000, Santa Cruz). Chemiluminescence detection
was performed using ECL reagents (GE healthcare, Little Chalfont, Buckinghamshire,
UK).
Superoxide detection with fluorescent microscopy. Hydroethidine (HEt), a cell
permeable fluorescence probe, was used to detect the production of superoxide
anions in cells. HEt can be oxidized by superoxide to form the fluorescent 2-hydroxy-
ethidium (2-OH-E1)46. In the experiments, after exposed to oxidative stress
treatments, cells were incubated with 10 mM HEt for 15 min at room temperature.
After washing with PBS, cells were kept in phenol red-free medium for observation
under fluorescent microscope.
Superoxide detection with flow cytometery. Intracellular superoxide level was
quantified with flow cytometery. After cells were treated with MSB and incubated
with HEt, the cell pellets were collected and suspended in 500 ml PBS for
measurement. The HEt-positive staining cells were counted by flow cytometer
(EPICS XC, Beckman Coulter, Kraemer Boulevard Brea, CA, USA) with a laser
emitting excitation light at 488 nm and the emission 575 nm.
Apoptosis detection with flow cytometery. Double staining with fluorescenin
isothiocyanate conjugated with annexin V and propidium iodide were used to detect
apoptotic cell death. After treatment, cells were collected and resuspended in 1 3
Annexin V binding buffer. After incubation with 53 Annexin V-PE for 15 min,
positive staining rates were counted with flow cytometer using a single laser-emitting
excitation light (488 nm) and the emission signal (575 nm) generated by Annexin
V-PE.
Lactate dehydrogenase (LDH) release assay. LDH release assay was used to detect
oxidative stress-mediated cell injury. Briefly, culture medium (50 ml) was collected
and incubated with 50 ml of the reaction mixture from the Cytotoxicity Detection Kit
(Invitrogen) for 30 min at room temperature (24uC). The optical density of the
solution was measured at 490 nm on a 3350 microplate reader (Bio-Rad, Hercules,
CA, USA). Medium collected in the well without cells was used as negative control
counting as 0%. Triton-X 100-treated cell medium was used as 100% cell death
control. The rates of cell death were calculated by using the formula: Cell death rate
(%) 5 (Experimental absorbance value - culture medium absorbance value)/(Triton-
X 100-treated absorbance value - culture medium absorbance value) 3 100%.
NADPH oxidase activity. NADPH oxidase activities were assayed with lucigenin
enhanced chemiluminescence method as previous described47–49. Briefly, cells were
suspended and lysed inNADPH lysis buffer (50 mMphosphate buffer, pH 7.0, 1 mM
EGTA, 150 mM sucrose, and protease inhibitors). Total cell lysate containing 100 mg
proteins were incubatedwith 10 mmol diethyldithiocarbamic acid (Sigma) at 37uC for
30 min. Then mixtures were treated with 5 mmol lucigenin (Sigma) and 0.1 mmol
NADPH (Sigma) balanced with NADPH lysis buffer. After incubation for 10 min at
37uC in dark, the samples were detected with luminometer. Reactions were
terminated with 10 mmol tiron (Sigma). The enzyme activity was expressed as relative
light units/mg protein and relative fold changes were used to indicate the activity
changes.
Statistic analysis.Datawere expressed asMeans6 S.D. Formultiple groups designed
experiments, comparisons weremade by one-way analysis of variance (ANOVA) and
followed by Dunnett test for two group comparison within the multiple groups. For
two groups designed experiments, comparisons were determined using unpaired
Student’s t-test. Statistic analysis was performed in the SPSS 16.0 statistical program
(SPSS, Chicago, IL, USA). p, 0.05 was considered to be statistically significant in the
compared groups.
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